Read, Learn, Innovate: Top Blog Posts from September 2019
ISPE
Featured in this edition of iSpeak Reading Roundup, are the top blog posts from September 2019. Explore key insights for process innovation, distillation technologies, validation strategies, and more for what the pharmaceutical industry was reading last month.
Eli Lilly is the 2019 ISPE Facility of the Year Category Winner for Process Innovation for their IE2 Small Volume Continuous Facility located in Kinsale, County Cork, Ireland. See how they enabled the manufacturing of multiple steps of a drug substance process simultaneously to reduce the time required to bring medicine to the patient.
Discover the impact of a fully electronic solution to issues with paper-based documentation of process validation procedures and outcomes. Sustainability of critical validation documents and the transformation to fully electronic databases are examined in this article.
This three-part technology overview delves into design considerations with different distillation methods and focuses on the latest available technologies, end-user perspective in facility design, and restrictions for product-specific manufacturing.
Explore a plan for continued process verification and the crucial parameters and attributes necessary for successful GMP bioprocess. This plan at its core evaluates close attention to statistical accuracy and managing process vulnerabilities.
Hear from validation expert, Miguel Montalvo, on common challenges in implementing a successful cleaning validation program in facilities housing modernized equipment and medicines. This article features ten specific issues for cleaning validation that industry professionals can recognize and solve.
ISPE delivers technical and operational solutions to support across the global pharmaceutical and biopharmaceutical industry in the manufacture of quality medicines for patients.
The International Council for Harmonization of Technical Requirements for Pharmaceuticals for Human Use (ICH) has recently announced the adoption of the revised guideline
The outlook for the biopharmaceutical market is promising, with expectations that the market will double in the next 10 years, resulting in new therapies and advances in biopharmaceutical manufacturing. This doesn't sound like much at first, but if you consider how the market has developed over the last 20 years, a doubling in the next 10 years is very significant.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.